CN114933970A - 缺失6-磷酸葡萄糖酸脱氢酶1基因的弓形虫基因敲除虫株 - Google Patents

缺失6-磷酸葡萄糖酸脱氢酶1基因的弓形虫基因敲除虫株 Download PDF

Info

Publication number
CN114933970A
CN114933970A CN202210723393.3A CN202210723393A CN114933970A CN 114933970 A CN114933970 A CN 114933970A CN 202210723393 A CN202210723393 A CN 202210723393A CN 114933970 A CN114933970 A CN 114933970A
Authority
CN
China
Prior art keywords
gene
strain
toxoplasma
tg6pgdh1
toxoplasma gondii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210723393.3A
Other languages
English (en)
Other versions
CN114933970B (zh
Inventor
夏宁波
郭庆红
冯耀宇
肖立华
郭雪芳
姬诺
李娜
郭亚琼
元冬娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Provincial Laboratory Of Lingnan Modern Agricultural Science And Technology
South China Agricultural University
Original Assignee
Guangdong Provincial Laboratory Of Lingnan Modern Agricultural Science And Technology
South China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Provincial Laboratory Of Lingnan Modern Agricultural Science And Technology, South China Agricultural University filed Critical Guangdong Provincial Laboratory Of Lingnan Modern Agricultural Science And Technology
Priority to CN202210723393.3A priority Critical patent/CN114933970B/zh
Publication of CN114933970A publication Critical patent/CN114933970A/zh
Application granted granted Critical
Publication of CN114933970B publication Critical patent/CN114933970B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10Protozoa; Culture media therefor
    • C12N1/105Protozoal isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01049Glucose-6-phosphate dehydrogenase (1.1.1.49)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/90Protozoa ; Processes using protozoa
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

本发明公开了一种弓形虫基因敲除虫株,该虫株缺失核苷酸序列如SEQ ID No.1所示的弓形虫6‑磷酸葡萄糖酸脱氢酶1基因(Tg6PGDH1)。本发明还公开了该虫株的构建方法以及在制备弓形虫疫苗中的应用。所述弓形虫基因敲除虫株在体外可以正常培养,虫体可以正常生长复制,但是在体内毒力减弱且对动物具有很高的免疫保护力,有成为抗弓形虫基因工程疫苗的潜力。

Description

缺失6-磷酸葡萄糖酸脱氢酶1基因的弓形虫基因敲除虫株
技术领域
本发明涉及一种弓形虫基因敲除虫株,具体是缺失6-磷酸葡萄糖酸脱氢酶1基因(Tg6PGDH1基因)的弓形虫基因敲除虫株,本发明还涉及该虫株的构建方法以及用途。
技术背景
弓形虫是从属于顶复门的一种专性细胞内寄生原虫,感染包括人在内的几乎所有温血动物,入侵宿主各种有核细胞。弓形虫生活史复杂,其既可以在终末宿主猫中进行有性繁殖,又可以在人、猪、牛和羊等其他中间宿主中进行无性繁殖。弓形虫具有多种致病形态,如速殖子、缓殖子以及卵囊等。弓形虫感染严重危害人类健康和畜禽养殖业发展,造成巨大的社会问题和经济损失。但是,弓形虫病尚无理想的疫苗。当前仅有一个弱毒S48虫株被授权成为了商业疫苗,但是,该疫苗仅在绵羊中使用,且存在毒力返强的风险。因此,迫切需要发掘更多的疫苗设计靶点,研制新型抗弓形虫病的疫苗。
针对弓形虫病的防控手段有限,而虫体中重要的代谢途径可以成为潜在的疫苗设计靶点。磷酸戊糖代谢途径(PPP)是弓形虫葡萄糖分解代谢的主要途径之一,但是其受关注度低。本发明通过遗传学手段分析PPP代谢酶在弓形虫生长发育中的生物学作用,挖掘出了一个具有良好潜力的疫苗设计靶点,发现在II型野生型虫株ME49中缺失Tg6PGDH1后,虫体在体外可以正常传代培养,但是显著降低体内毒力,表明:弓形虫Tg6PGDH1是一个有良好应用潜力的疫苗设计靶点。ME49Δ6pgdh1是一株减毒的弓形虫候选疫苗虫株,其应用对于弓形虫病的防治具有重要价值和意义。
发明内容
本发明的目的在于提供一种弓形虫基因敲除虫株及其构建方法和应用,该虫株敲除了6-磷酸葡萄糖酸脱氢酶1基因(Tg6PGDH1基因),其在体外可以正常传代培养,但是具有毒力低,在动物体内繁殖少等优点,能提高动物对弓形虫的免疫能力,有制备抗弓形虫基因工程疫苗的潜力。
本发明的技术方案为:
(1)本发明所述弓形虫基因敲除减毒虫株(ME49Δ6pgdh1)的构建:构建pSAG1-Cas9-TgU6-sgTg6PGDH1质粒;制备Tg6PGDH1-5UTR::DHFR*::Tg6PGDH1-3UTR同源模板;将二者共电转至野生型ME49虫株中,经乙胺嘧啶药物筛选和PCR鉴定获得弓形虫基因敲除虫株ME49Δ6pgdh1。
(2)ME49Δ6pgdh1虫株的体外生长试验:ME49和ME49Δ6pgdh1虫体分别感染人成纤维细胞(HFF),进行体外12天的空斑试验和24小时的复制试验。结果表明:ME49和ME49Δ6pgdh1在体外的空斑形成能力和复制能力没有显著差异,表明缺失Tg6PGDH1不影响虫体体外的正常生长。
(3)ME49Δ6pgdh1虫株的体内毒力试验:以野生型ME49虫株为对照,按照1×102个弓形虫速殖子/小鼠(每组接20只),或者按照1×103个虫体/小鼠(每组接10只),腹腔接种6周龄雌性ICR小鼠,记录30天内小鼠的存活情况。结果表明:感染1×102个或者1×103个ME49Δ6pgdh1虫体的小鼠30天内存活率为80%,而接种野生型ME49虫体的小鼠30内存活率在20%左右。表明:缺失Tg6PGDH1显著降低虫体体内毒力。
(4)ME49Δ6pgdh1虫株对小鼠的免疫保护力:以100个ME49Δ6pgdh1速殖子每只小鼠的感染量接种ICR小鼠,每组8只。30天后对免疫接种过ME49Δ6pgdh1的小鼠及空白ICR小鼠(每组8只)接种1×104个野生型ME49虫体,观察并记录小鼠死亡情况,统计小鼠30天内的死亡率。结果表明:免疫接种ME49Δ6pgdh1虫株,对小鼠抵抗野生型虫体感染具有良好的免疫保护力。ME49Δ6pgdh1虫株有成为基因工程疫苗的潜力。
更详尽的技术方案参见具体实施例。
附图说明
图1:敲除弓形虫Tg6PGDH1的策略示意图。
图2:ME49Δ6pgdh1的单克隆虫株PCRs鉴定图。
图3:ME49Δ6pgdh1虫株体外空斑实验。
图4:ME49Δ6pgdh1虫株体外复制实验。
图5:感染1×102个ME49Δ6pgdh1虫体对小鼠的毒力试验。
图6:感染1×103个ME49Δ6pgdh1虫体对小鼠的毒力试验。
图7:ME49Δ6pgdh1虫株对小鼠的免疫保护力试验。
具体实施方式
下面结合实施例对本发明进行详细说明。
实施例1:弓形虫ME49Δ6pgdh1虫株的构建
(1)pSAG1-Cas9-TgU6-sg6PGDH1质粒的构建
①用gRNA在线设计网站(http://www.e-crisp.org/E-CRISP/designcrispr.html)对Tg6PGDH1打靶位点进行设计,根据所设计的靶点序列设计如表1的引物:
表1.构建Tg6PGDH1特异性CRISPR/Cas9质粒所使用的引物
Figure BDA0003712480580000031
②以pSAG1-Cas9-TgU6-sgUPRT质粒(购自http://www.addgene.org)为模板,进行Tg6PGDH1特异性CRISPR/Cas9质粒的构建,PCR体系和反应条件如下:
Figure BDA0003712480580000032
PCR反应条件如下:
Figure BDA0003712480580000033
PCR结束以后,在PCR反应体系里直接加1μL DpnI,37℃进行消化45min。
③取新的灭菌PCR管,配制如下反应体系:
Figure BDA0003712480580000034
在PCR仪中,25℃反应15min;
④取全部反应产物转化入100μL的DH5α大肠杆菌感受态细胞中,涂LB/Amp+平板,37℃倒置培养8-12h;挑取单菌落置于1mL LB/Amp液体培养基中,37℃/180rpm振荡培养至菌液浑浊;取500μL菌液进行测序分析,若测序结果显示靶点序列已完全被替换,即pSAG1-Cas9-TgU6-sgTg6PGDH1质粒构建成功。
(2)Tg6PGDH1-5UTR::DHFR*::Tg6PGDH1-3UTR同源模板的制备
①利用表2中的引物,使用KD plus高保真酶分别从弓形虫ME49基因组DNA中扩增获得5’同源臂和3’同源臂片段;从带DHFR*的质粒(购自http://www.addgene.org)中扩增获得DHFR*片段;利用所设计的特异性引物线性化pUC19载体(购自http://www.addgene.org),分别对上述目的片段进行回收,并利用NanoDrop2000测定回收产物浓度。
表2.构建pTg6PGDH1-5UTR::DHFR*::Tg6PGDH1-3UTR质粒引物
Figure BDA0003712480580000041
④根据回收产物的浓度配制如下反应体系:
Figure BDA0003712480580000042
Figure BDA0003712480580000051
充分混匀后,37℃反应30min,冰上放置5min;
⑤将10μL连接产物全部转化入100μL的DH5α感受态细胞中,涂LB/Amp+平板,37℃倒置培养10-12h;挑取单菌落置于含5mL LB/Amp+液体培养基的无菌PV玻璃瓶中,37℃/180rpm振荡培养10h至菌液浑浊;进行测序分析,若测序结果正确即可认为p6PGDH1-5UTR::DHFR*::6PGDH1-3UTR质粒构建成功,遂将鉴定正确的菌液进行质粒提取,-20℃保存,该正确质粒的核苷酸序列如SEQ ID NO:2所示。
⑥利用高保真酶对p6PGDH1-5UTR::DHFR*::6PGDH1-3UTR质粒进行PCR扩增,扩增引物为U56PGDH1-Fw上游引物和U36PGDH1-Rw下游引物,对同源模板进行切胶回收并测定浓度,-20℃保存备用。
(3)弓形虫基因敲除虫株ME49Δ6pgdh1的构建
①收取新鲜的弓形虫ME49速殖子,利用无菌的3μm孔径滤膜过滤除掉宿主细胞碎片,3000rpm离心10min;弃上清,用Cytomix(120mM KCl,0.15mM CaCl2,10mM K2HPO4/KH2PO4,25mM HEPES,2mM EGTA,5mM MgCl2,pH=7.6)重悬虫体沉淀至虫体量约为1×107个速殖子/mL;
②取250μL左右的虫体悬液到电转杯中,加入pSAG1-Cas9-TgU6-sgTg6PGDH1质粒和p6PGDH1-5UTR::DHFR*::Tg6PGDH1-3UTR同源模板,其中质粒和同源模板DNA摩尔比=5:1,转染DNA的总量约为10μg,总体积300μL左右;
③用移液枪将DNA和野生型ME49虫体混合均匀于4mm电转杯中,并去除气泡;将电转杯置于Bio-Rad电转仪内,设置1600V、25μF、50Ω、4mm条件,电击一次,1500V、25μF、50Ω、4mm条件,电击两次;
④在电转杯中立即加入1mL虫体培养液(DMEM+2%FBS+双抗)轻轻冲洗,再将该液体转移至新鲜的人成纤维细胞(HFF)细胞中进行培养和观察;
⑤在40-60%转染后的虫体逸出HFF宿主细胞后,用5mL注射器吹打细胞,将细胞裂解,使虫体从宿主细胞中释放出来;取500μL虫体悬液加入到新鲜的HFF宿主细胞中,在该培养基中加入1μM乙胺嘧啶筛选;
⑥在乙胺嘧啶作用3天后,可见宿主细胞内出现虫体增殖现象,在50%虫体从宿主细胞内逸出时将细胞裂解使虫体释放,取500μL虫体传到新鲜的HFF细胞中,再进行药物筛选;
⑦在经过3-4代药物筛选后,将虫体置于含有HFF细胞的96孔板中进行单克隆筛选,每孔接种1个弓形虫速殖子;剩余虫体可进行基因组gDNA的提取,并利用表3中的引物,图1所示方法检测同源臂整合效率和基因敲除效率,PCR1有条带说明Tg6PGDH1的5’同源臂整合入弓形虫基因组中,PCR2有条带说明Tg6PGDH1的3’同源臂整合入弓形虫基因组中,PCR3条带检测敲除基因Tg6PGDH1是否还在基因组中,若对照组ME49有PCR3条带,而转染实验组无PCR3条带,则说明Tg6PGDH1被成功敲除。
表3.ME49Δ6pgdh1的单克隆虫株PCRs鉴定引物
Figure BDA0003712480580000061
⑧在96孔板中培养10天后观察是否存在单克隆,利用无菌枪头将含有单克隆的宿主细胞从孔内刮下,加入到含有HFF宿主细胞的24孔板中,继续培养;当24孔板中有50%-60%的HFF细胞被裂解时,即可将孔内的虫子150μL传到新的24孔板中培养,其余的用于DNA提取以鉴定单克隆;
⑨利用PCR1,PCR2和PCR3对挑选的单克隆虫株进行检测,若PCR1和PCR2有特异性条带,而PCR3无目的带说明该单克隆虫株为基因敲除虫株ME49Δ6pgdh1;将确定为ME49Δ6pgdh1的虫株继续扩大培养至T25培养瓶;对T25培养瓶中的基因敲除虫株再次进行PCR1,PCR2和PCR3检测,PCR反应体系如下,若仍为敲除表型即可在扩大后进行冻存;
在灭菌PCR管中配制如下反应体系:
Figure BDA0003712480580000071
PCR反应条件如下:
Figure BDA0003712480580000072
⑩PCR产物鉴定:扩增完成后,取PCR产物10μL,加2μL的6×核酸上样缓冲液混匀,点样,1.0%琼脂糖凝胶,1×TAE缓冲液,120V,电泳30min,凝胶成像系统观察,PCR鉴定结果如图2所示,表明ME49Δ6pgdh1的单克隆虫株构建成功。
实施例2:弓形虫ME49Δ6pgdh1虫株的体外实验
2.1空斑实验
①对新鲜溢出的ME49和ME49Δ6pgdh1弓形虫速殖子用灭菌的3μm滤膜过滤、纯化和稀释,用细胞计数板对虫体进行计数;
②向长满HFF细胞的6孔板中接种虫体(100个弓形虫/每孔),接种后的6孔板37℃、5%CO2培养箱中培养12d;
③用PBS对6孔板洗1-2次,用4%多聚甲醛室温固定6孔板细胞20min,PBS洗1次;
④用0.1%结晶紫对细胞室温染色15min,PBS洗1次,室温晾干;
⑤用扫描仪扫描图片,用PS软件进行空斑面积的测量,进行Student's t test分析,结果如图3。
结果表明:缺失Tg6PGDH1不影响虫体体外噬斑的形成。
2.2弓形虫速殖子复制实验
①收集、过滤和纯化的新鲜溢出的ME49和ME49Δ6pgdh1虫体,接种至长满HFF细胞的24孔板爬片上,在37℃、5%CO2培养箱中入侵HFF细胞1h;
②加入PBS洗2-3次,洗去未入侵虫体,在37℃、5%CO2培养箱中继续培养虫体24h;
③培养24h后,用4%多聚甲醛对24孔板中的细胞进行固定15min;
④猪抗弓形虫阳性血清孵育20min,PBS洗3次;
⑤0.1%Triton X-100透化细胞20min;
⑥用10%的FBS在4℃条件下封闭过夜,PBS洗3次;
⑦兔抗弓形虫ALD孵育20min,PBS洗3次;
⑧羊抗猪二抗、羊抗兔二抗和Hoechst(1:1000稀释)作用15min,PBS洗3-5次;
⑨封片,荧光显微镜下观察,记录并统计纳虫泡中虫体个数为1个、2个、4个、8个、大于或等于16个的纳虫泡数量,每组统计至少100个纳虫泡,实验单独重复至少3次,进行two-way analysis of variance分析,结果如图4。
结果表明:缺失Tg6PGDH1不影响虫体体外的复制。
实施例3:弓形虫ME49Δ6pgdh1虫株的体内实验
3.1 ME49Δ6pgdh1虫体对小鼠毒力实验
①使用HFF细胞体外培养弓形虫速殖子,待有30-50%虫体逸出细胞,弃掉原培养瓶中的培养基,用PBS洗去已逸出的虫体和残留的培养基,加入新鲜不含FBS的DMEM稀释液。
②用一次性细胞刮将细胞刮下,5mL注射器反复吹打悬液8-10次,使纳虫泡破裂,虫体逸出,用无菌的3μm孔径滤膜过滤纯化虫体,用细胞计数板对虫体悬液进行计数。
③以无血清的DMEM溶液为注射液,按照1×102个虫体/小鼠,腹腔接种6周龄雌性ICR小鼠(每组接20只),或者按照1×103个虫体/小鼠,腹腔接种6周龄雌性ICR小鼠(每组接10只),每天记录小鼠的存活情况,30天后对结果进行统计,进行Gehan–Breslow–Wilcoxontests分析。结果如图5和图6所示:接种ME49Δ6pgdh1虫体的小鼠30天内存活率为80%,而接种野生型ME49虫体的小鼠30内存活率在20%左右。
结果表明:缺失Tg6PGDH1显著降低虫体体内毒力。
3.2 ME49Δ6pgdh1虫株对小鼠免疫保护力实验
①用无血清的DMEM溶液为注射液,以102个ME49Δ6pgdh1速殖子每只小鼠的感染量接种ICR小鼠,每组8只。
②30天后对免疫过的小鼠及未经免疫的对照ICR小鼠(每组8只)接种1×104个ME49野生型虫体。
③观察、记录小鼠死亡情况,30天后统计小鼠死亡率,进行Gehan–Breslow–Wilcoxon tests分析,如图7,对照组小鼠在14天内全部死亡,经ME49Δ6pgdh1免疫过的小鼠在30天内均没有死亡,说明免疫接种ME49Δ6pgdh1虫体对小鼠抵抗野生株虫株感染具有良好的免疫保护力。ME49Δ6pgdh1虫体有成为基因工程疫苗的潜力。
序列表
<110> 华南农业大学
<120> 缺失6-磷酸葡萄糖酸脱氢酶1基因的弓形虫基因敲除虫株
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2560
<212> DNA
<213> 弓形虫(Toxoplasma gondii)
<400> 1
atgtcttgtg acgttggcat ttacggtctg gccgtaatgg gccttggact gtctctgaac 60
ctcgcgagtc ggggaattcg agtctctgtg tgcaatcgta catccacaaa agtagatgga 120
gcattgaaac aggcgaaaga cgagaatttc gaagaaaata tttttggagc tcggacactt 180
gaagactttg tgagtcacta ttttcccatt ccgccccgat gagcatgtgt ggcgaactcg 240
aatgttctac cgtgttcaaa atctgccgtc accatttctg tcggcatgtt acgcaggtgc 300
agtcgctgaa aaagccgcgt cgaattatca tggttattga ggtatgccac cagacgagtc 360
cctccgaagc gaacacatta aaaacgtgtt caaccgtttt tgcatctttt acgtgtttca 420
ggcaggagcc ccagtcgatg cgctcatcaa tcacctgcta ccaaagttag atgcaggtga 480
ctgccttgtg gatgctggaa atgagttctt tgaagtctcc gaaaaaaggg aacgactgtg 540
tgcttcgaaa ggcgtcctgt aagtacttcg gagacaaatt gtttacctgt ccagttatgc 600
cgatggttgc aacgtcctac ctaccatatt ctgtatactg cagttttatg gacgttggac 660
tctgcgcggg agagggcggc gctcggtctg ggcctccatt gacgccagga gggagccttg 720
aggcatggaa cctgatggag ccaattttcg ttcaactcgc cggaaagatt gacgcgtcga 780
agacaatacc tcttcctgga gccctcactg ttagcgatga agagaagcaa aatgcatgcg 840
tcagccatct aggaccctgc ggcgctggac attacgttaa aatggtccac aacggtataa 900
tgtatggcga catgcagctc attgccgagg taagacggtt tcgtatggcc tgaccacata 960
gcaaatccac aacaaacaat cataagaata gggggatcgg aaacaccccg taacctaatg 1020
gaaacgtcct attatttgtc cagcttacag ctttcttctg agtaacgaat aaaaaaaagt 1080
acggtggagc tatcgcatcc caataactca acacccgtaa atcattttta tgtacagcag 1140
taacttcaga aatggaccag gcgtagacca aaccgcgatg gaagaaaaac taatctgcaa 1200
tgattctcta gagaatttga ctgaaagagt tttgcccgcc taatacaaca ttttgcactt 1260
tcggcgcact actgttctgt acagctgtcc ttccgtttct gatttgacgc tctcgccagg 1320
ctcaccaact gctaaaattc gcttgtgatc tgagcaatga ggaacttcat gtcacgttta 1380
aaaagtggaa tgaagacgag cttcactcat atcttcttgg aattacggcc aacatcgtcc 1440
gcaagaagga tagctttacc ggaggtgagt tatttgcttt cacctgtccg caggcgtgtg 1500
gtatctgcaa caccatcagg cgcaggcgtc tgtgtgcgga tgccttcttc acacaggcta 1560
ccttttggat ttcattgccg acacagcggg atcaaaagga acaggcaaat ggaccatgca 1620
acaagcagca gagttgggtg ttgctgtgcc aaccatcaca gctgccctcg acatgcgata 1680
catatgctca aaccagcctt tgcggcagaa gatgaactgt ctttacgccc aaaactggtg 1740
ctctcttgtg aaaacagagg attccacgaa ggaacagcgc atcggtaaga ctagcagtat 1800
tttcgattga gttccatgat tcgatgtcgc agagttaatc ttgcgtttgg cgtgtgtgtg 1860
catttgtact aacatgtctc agagtccatc agacgagcgt tagtttgtgg aaggatatgc 1920
tgcttcgctc aaggcatgca cctcctacgt gttatatccg aacaaaaagg atggggagta 1980
gatctgtctg aggtctcacg aatttggcaa ggtgagatgg agctcgaaac tctccttgac 2040
atctgcaaca ttcgaaacgc ttgtcagttc acggaggtgc gagtccttac gtgctacgaa 2100
ttgccttgtt tattcagccg gttgcgtcat cgagtgcgac ttcctgaaag tcatgcaacg 2160
tgcgttccgg aagaagccgg acctggaaag cattctcctc tccgaagagt aagttcataa 2220
tttccctttt attatcgctg tttgacacac ttttctgcat gtttcccatc cttcgatgtt 2280
cgcgtacagg gtccacacga cggtccaaaa ctaccttccg gcattgcaag aagttatcag 2340
cttatcgcta ggaacagcaa cccccaggcc ggatgagccc tctgtcagaa ttacccttcc 2400
cacaccggca cattcagctt cgtataacta cctggcgtcc agttgtggcc tccgcctttc 2460
aatgaatctc gttcaagctc agcgtgattg ctttggtgca catcacttca agagaactga 2520
tcgggaagga aagtaccacg ttgaagactg gggggcctaa 2560
<210> 2
<211> 7870
<212> DNA
<213> 人工序列(Artificial sequence )
<400> 2
tcgcgcgttt cggtgatgac ggtgaaaacc tctgacacat gcagctcccg gagacggtca 60
cagcttgtct gtaagcggat gccgggagca gacaagcccg tcagggcgcg tcagcgggtg 120
ttggcgggtg tcggggctgg cttaactatg cggcatcaga gcagattgta ctgagagtgc 180
accatatgcg gtgtgaaata ccgcacagat gcgtaaggag aaaataccgc atcaggcgcc 240
attcgccatt caggctgcgc aactgttggg aagggcgatc ggtgcgggcc tcttcgctat 300
tacgccagct ggcgaaaggg ggatgtgctg caaggcgatt aagttgggta acgccagggt 360
tttcccagtc acgacgttgt aaaacgacgg ccagtgaatt cgaggacgat gagcagacgt 420
caagtcacta gcagttgacg cttcccgctc catctgattc ccttttctga gcatcacgtg 480
gccgtgtgac tcgacatgcc accccattaa tttatgtatt ggttccaagg acccaggcgt 540
gctggtcatc ttgtgtcaac ctcgcccgac agtcgacaga atgtttgagt ctgaccccca 600
accacagcac ggtcttcaca tttcattcac atgactattt tatctatcta cggaccaatt 660
gcgacaccag ttcatccgat ttctgcttat cttacaggtg gcctaaaaag cggtttaggg 720
aggtctcgac taagtcactt tgcaggagac ggccccaatt atcaactcca cggtagtcca 780
aaacatcggc agaaattaag acacggttgt catgtgcgca ggcgccgagt ggcccagaaa 840
aaccgtgcct tctatactcg aaggcggtga tccctctagt cattgccgat gaagctgttt 900
atgccgtctg tctacactac actatcagca cgaggaatcc agccgacctg ccgagcatgg 960
atggccatat gaagacacgg gcagctgttc tctgaaacga actccaccgt cagacctcac 1020
acgattctcg tcttaaacgt tctacttcac atctgtagcc atgaaatgtt ggctgtgtaa 1080
gaatttgtag cattttttag ctcacaggtt gaatttgttt tctcgcactg aggaaggcta 1140
tttcaaaacg attcctctgc gattcggcag acagccgcgg aggaagctgg ggtgaatcga 1200
tggcctattc gataccccac caacatcatc cgttgtacag agcttttaca tctgtcaacc 1260
tcggcgcact actcgttggc attttttcta taacttcgta tagcatacat tatacgaagt 1320
tatagaattc cgacaaaatg gaggtccata ctaaccaaga tccacttgac cctaggatga 1380
gaggatcggg atccatgggt tcagagggcc aggctgtaaa tcccgtgagt cgtcctcaca 1440
aatcatcaag caggtgtcct cagggagact gcctgactga gttatgctaa ttcctttcta 1500
ctttggcgtg gtcacggggg cgcgccggat ccttaattaa gtctagcatg tcattcgatt 1560
ttcacccccc gcgtagttcc tgtgtgtcat tcgttgtcga gacaactctg tcccgccccg 1620
gtgctgttcc atatgcgtga ctttcccgca attttttcag actttcagga aagacaggct 1680
ccggaacgat ctcgtccatg actggtaaat ccacgacacc gcaatggccc ccagcacctc 1740
tatctctcgt gccaggggac taacgttgta tgcgtctgcg tcttgtcttt ttgcattcgc 1800
tttccaaaaa agagagccat ccgttccccc gcacattcaa cgccgcgagt gcggtttttg 1860
tcttttttga gtggtaggac gcttttcatg cgcgaactac gtggacatta agttccattc 1920
tctttttcga cagcacgaaa ccttgcattc aaacccgccc gcggaagatc cgatcttgct 1980
gctgttcgca gtcccagtag cgtcctgtcg gccgcgccgt ctctgttggt gggcagccgc 2040
tacacctgtt atctgactgc cgtgcgcgaa aatgacgcca tttttgggaa aatcggggaa 2100
cttcattctt taaaagtatg cggaggtttc ctttttcttc tgttcgtttc tttttctcgg 2160
gtttgataac cgtgttcgat gtaagcactt tccgtctctc ctccgtgctt tgttcgacat 2220
cgagaccagg tgtgcagatc cttcgcttgt cgatccggag acgcgtgtct cgtagaacct 2280
tttcatttta ccacacggca gtgcggagca ctgctctgag tgcagcaggg acgggtgaag 2340
tttcgcttta gtagtgcgtt tctgctctac ggggcgttgt cgtgtctggg aagatgcaga 2400
aaccggtgtg tctggtcgtc gcgatgaccc ccaagagggg catcggcatc aacaacggcc 2460
tcccgtggcc ccacttgacc acagatttca aacactttcg tcgtgtgaca aaaacgacgc 2520
ccgaagaagc cagtcgcctg aacgggtggc ttcccaggaa atttgcaaag acgggcgact 2580
ctggacttcc ctctccatca gtcggcaaga gattcaacgc cgttgtcatg ggacggaaaa 2640
actgggaaag catgcctcga aagtttagac ccctcgtgga cagattgaac atcgtcgttt 2700
cctcttccct caaagaagaa gacattgcgg cggagaagcc tcaagctgaa ggccagcagc 2760
gcgtccgagt ctgtgcttca ctcccagcag ctctcagcct tctggaggaa gagtacaagg 2820
attctgtcga ccagattttt gtcgtgggag gagcgggact gtacgaggca gcgctgtctc 2880
tgggcgttgc ctctcacctg tacatcacgc gtgtagcccg cgagtttccg tgcgacgttt 2940
tcttccctgc gttccccgga gatgacattc tttcaaacaa atcaactgct gcgcaggctg 3000
cagctcctgc cgagtctgtg ttcgttccct tttgtccgga gctcggaaga gagaaggaca 3060
atgaagcgac gtatcgaccc atcttcattt ccaagacctt ctcagacaac ggggtaccct 3120
acgactccgt ggttctcgag aagagaagga agactgacga cgcagccact gcggaaccga 3180
gcaacgcaat gagctccttg acgtccacga gggagacaac tcccgtgcac gggttgcagg 3240
ctccttcttc ggccgcagcc attgccccgg tgttggcgtg gatggacgaa gaagaccgga 3300
aaaaacgcga gcaaaaggaa ctgattcggg ccgttccgca tgttcacttt agaggccatg 3360
aagaattcca gtaccttgat ctcattgccg acattattaa caatggaagg acaatggatg 3420
accgaacggg cgttggtgtc atctccaaat tcggctgcac tatgcgctac tcgctggatc 3480
aggcctttcc acttctcacc acaaagcgtg tgttctggaa aggggtcctc gaagagttgc 3540
tgtggttcat tcgcggcgac acgaacgcaa accatctttc tgagaagggc gtgaagatct 3600
gggacaagaa tgtgacacgc gagttcctcg attcgcgcaa tctcccccac cgagaggtcg 3660
gagacatcgg cccgggctac ggcttccagt ggagacactt cggcgcggca tacaaagaca 3720
tgcacacaga ctacacaggg cagggcgtcg accagctgaa gaatgtgatc cagatgctga 3780
gaacgaatcc aacagatcgt cgcatgctca tgactgcctg gaatcctgca gcgctggacg 3840
aaatggcgct gccgccttgt cacttgttgt gccagttcta cgtgaacgac cagaaggagc 3900
tgtcgtgcat catgtatcag cggtcgtgcg atgtcggcct cggcgtcccc ttcaacatcg 3960
cttcctattc gcttttgacg ctcatggttg cacacgtctg caacctaaaa cctaaggagt 4020
tcattcactt catggggaac acgcatgtct acacgaacca tgtcgaggct ttaaaagagc 4080
agctgcggag agaaccgaga ccgttcccca ttgtgaacat cctcaacaag gaacgcatca 4140
aggaaatcga cgatttcacc gccgaggatt ttgaggtcgt gggctacgtc ccgcacggac 4200
gaatccagat ggagatggct gtctagcgga aatacagaag ctgcccgtct ctcgttttcc 4260
tctcttttcg gagggatcag ggagagtgcc tcgggtcgga gagagctgac gagggggtgc 4320
cagagacccc tgtgtccttt atcgaagaaa agggatgact cttcatgtgg catttcacac 4380
agtctcacct cgccttgttt tctttttgtc aatcagaacg aaagcgagtt gcgggtgacg 4440
cagatgtgcg tgtatccact cgtgaatgcg ttatcgttct gtatgccgct agagtgctgg 4500
actgttgctg tctgcccacg acagcagaca actttccttc tatgcacttg caggatgaat 4560
tcctacccag ctttcttgta caaagtggtc gtctctagtt tttttgacag accgctgacg 4620
gaatcaggga caccagcgac aagcgcgacc acgtgtgcca gcgcgaggtg gcctacgccc 4680
acagcgtgcc ccgcatcacc agcgccatcg gtagcgacga ggatatgcat agatcttaat 4740
taataacttc gtatagcata cattatacga agttataaaa tggtgagcaa gggcgaggta 4800
gatttcgccg aaatgcttac ccgcgcaaat attgccttcg acgtctctct ggcgactgct 4860
tggagtgggc ccttactacc tgtcactttt ccagctggaa tcattataag aggatcttgg 4920
gcagcgaagc cgatatgcgg ccagaattca ataacaacgt gacttcgtac tttatccggc 4980
accggattat cacctgattg gattttaaag cactgttaaa ccgccgaatt gctaggtgaa 5040
agttaatgtt cacctaatag aaatttatag cccgctgaac cagtggagca tttccaggac 5100
agcttcaaaa tcccgaaata tgcactcggc cacggtttca aagacacggc aaatgtatat 5160
gcacatgacc ttaagctttt tttacgtgcc gcgtcgcatc cagactctat tgaggggcag 5220
ttgtcctgaa tcgacgtaca acaacgatct gataccctga tgttcaactc aagcacgact 5280
tcctaaatgg tgcggcctca agaggtagcc tgacagtgac aagcagtatg atttaagact 5340
aaattacata agcggcagct tgtagattac cgatacacgc ttttccgccg tacttctttc 5400
acctctgctg tcacatccat aatgtatgct cggggccctc ctcacgttat acggatcagg 5460
ccttcggata cttcttggtt aaccaacacc gagagtggtg gtgctttcga aacacaatgc 5520
attgttagcc ttcacagcgc atagctcttt catccccaag cgtaggggtg cccctaatta 5580
cattgcctca actgtattaa gtactctgtg ctaatataca tgtcttggta tgctcaggcg 5640
taatcatggt catagctgtt tcctgtgtga aattgttatc cgctcacaat tccacacaac 5700
atacgagccg gaagcataaa gtgtaaagcc tggggtgcct aatgagtgag ctaactcaca 5760
ttaattgcgt tgcgctcact gcccgctttc cagtcgggaa acctgtcgtg ccagctgcat 5820
taatgaatcg gccaacgcgc ggggagaggc ggtttgcgta ttgggcgctc ttccgcttcc 5880
tcgctcactg actcgctgcg ctcggtcgtt cggctgcggc gagcggtatc agctcactca 5940
aaggcggtaa tacggttatc cacagaatca ggggataacg caggaaagaa catgtgagca 6000
aaaggccagc aaaaggccag gaaccgtaaa aaggccgcgt tgctggcgtt tttccatagg 6060
ctccgccccc ctgacgagca tcacaaaaat cgacgctcaa gtcagaggtg gcgaaacccg 6120
acaggactat aaagatacca ggcgtttccc cctggaagct ccctcgtgcg ctctcctgtt 6180
ccgaccctgc cgcttaccgg atacctgtcc gcctttctcc cttcgggaag cgtggcgctt 6240
tctcatagct cacgctgtag gtatctcagt tcggtgtagg tcgttcgctc caagctgggc 6300
tgtgtgcacg aaccccccgt tcagcccgac cgctgcgcct tatccggtaa ctatcgtctt 6360
gagtccaacc cggtaagaca cgacttatcg ccactggcag cagccactgg taacaggatt 6420
agcagagcga ggtatgtagg cggtgctaca gagttcttga agtggtggcc taactacggc 6480
tacactagaa gaacagtatt tggtatctgc gctctgctga agccagttac cttcggaaaa 6540
agagttggta gctcttgatc cggcaaacaa accaccgctg gtagcggtgg tttttttgtt 6600
tgcaagcagc agattacgcg cagaaaaaaa ggatctcaag aagatccttt gatcttttct 6660
acggggtctg acgctcagtg gaacgaaaac tcacgttaag ggattttggt catgagatta 6720
tcaaaaagga tcttcaccta gatcctttta aattaaaaat gaagttttaa atcaatctaa 6780
agtatatatg agtaaacttg gtctgacagt taccaatgct taatcagtga ggcacctatc 6840
tcagcgatct gtctatttcg ttcatccata gttgcctgac tccccgtcgt gtagataact 6900
acgatacggg agggcttacc atctggcccc agtgctgcaa tgataccgcg agacccacgc 6960
tcaccggctc cagatttatc agcaataaac cagccagccg gaagggccga gcgcagaagt 7020
ggtcctgcaa ctttatccgc ctccatccag tctattaatt gttgccggga agctagagta 7080
agtagttcgc cagttaatag tttgcgcaac gttgttgcca ttgctacagg catcgtggtg 7140
tcacgctcgt cgtttggtat ggcttcattc agctccggtt cccaacgatc aaggcgagtt 7200
acatgatccc ccatgttgtg caaaaaagcg gttagctcct tcggtcctcc gatcgttgtc 7260
agaagtaagt tggccgcagt gttatcactc atggttatgg cagcactgca taattctctt 7320
actgtcatgc catccgtaag atgcttttct gtgactggtg agtactcaac caagtcattc 7380
tgagaatagt gtatgcggcg accgagttgc tcttgcccgg cgtcaatacg ggataatacc 7440
gcgccacata gcagaacttt aaaagtgctc atcattggaa aacgttcttc ggggcgaaaa 7500
ctctcaagga tcttaccgct gttgagatcc agttcgatgt aacccactcg tgcacccaac 7560
tgatcttcag catcttttac tttcaccagc gtttctgggt gagcaaaaac aggaaggcaa 7620
aatgccgcaa aaaagggaat aagggcgaca cggaaatgtt gaatactcat actcttcctt 7680
tttcaatatt attgaagcat ttatcagggt tattgtctca tgagcggata catatttgaa 7740
tgtatttaga aaaataaaca aataggggtt ccgcgcacat ttccccgaaa agtgccacct 7800
gacgtctaag aaaccattat tatcatgaca ttaacctata aaaataggcg tatcacgagg 7860
ccctttcgtc 7870
<210> 3
<211> 20
<212> DNA
<213> 人工序列(Artificial sequence )
<400> 3
aacttgacat ccccatttac 20
<210> 4
<211> 40
<212> DNA
<213> 人工序列(Artificial sequence )
<400> 4
gggcctccat tgacgccagg gttttagagc tagaaatagc 40
<210> 5
<211> 40
<212> DNA
<213> 人工序列(Artificial sequence )
<400> 5
cgacggccag tgaattcgag gacgatgagc agacgtcaag 40
<210> 6
<211> 41
<212> DNA
<213> 人工序列(Artificial sequence )
<400> 6
gaaaaaatgc caacgagtag tgcgccgagg ttgacagatg t 41
<210> 7
<211> 41
<212> DNA
<213> 人工序列(Artificial sequence )
<400> 7
taaaatggtg agcaagggcg aggtagattt cgccgaaatg c 41
<210> 8
<211> 41
<212> DNA
<213> 人工序列(Artificial sequence )
<400> 8
gctatgacca tgattacgcc tgagcatacc aagacatgta t 41

Claims (10)

1.一种弓形虫基因敲除虫株,其特征在于:该虫株缺失核苷酸序列如SEQ ID No.1所示的弓形虫6-磷酸葡萄糖酸脱氢酶1基因(Tg6PGDH1基因)。
2.一种构建权利要求1所述弓形虫基因敲除虫株的方法,其特征在于包括以下步骤:
(1)以商业化的pSAG1-Cas9-TgU6-sgUPRT质粒为模板,设计Tg6PGDH1基因的打靶位点,根据打靶位点设计引物进行定点突变,将上述模板质粒中的sgUPRT替换为Tg6PGDH1基因靶点特异的gRNA,构建pSAG1-Cas9-TgU6-sg6PGDH1质粒;
(2)设计引物,构建包含Tg6PGDH1基因上下游同源臂的同源重组模板;
(3)将步骤(1)构建的pSAG1-Cas9-TgU6-sg6PGDH1质粒和步骤(2)构建的同源重组模板共电转至出发虫株,经药物筛选、PCR鉴定获得弓形虫Tg6PGDH1基因缺失虫株。
3.如权利要求2所述弓形虫基因敲除虫株的构建方法,其特征在于:所述Tg6PGDH1基因打靶位点的引物序列为:
引物名称 引物序列 gRNA-R 5’-AACTTGACATCCCCATTTAC-3’ gRNA-Tg6PGDH1-Fw 5’-GGGCCTCCATTGACGCCAGGGTTTTAGAGCTAGAAATAGC-3’。
4.如权利要求2所述弓形虫基因敲除虫株的构建方法,其特征在于:所述Tg6PGDH1基因上下游同源臂的引物序列为:
Figure FDA0003712480570000011
5.如权利要求2所述弓形虫基因敲除虫株的构建方法,其特征在于:所述同源重组模板的载体质粒是pUC19。
6.如权利要求2所述弓形虫基因敲除虫株的构建方法,其特征在于:所述同源重组模板中含有DHFR*药物筛选标签。
7.如权利要求2-6任一项所述弓形虫基因敲除虫株的构建方法,其特征在于:所述同源重组模板的核苷酸序列如SEQ ID No.2所示。
8.如权利要求2所述弓形虫基因敲除虫株的构建方法,其特征在于:所述出发虫株是弓形虫ME49株。
9.权利要求1所述的弓形虫基因敲除虫株在制备弓形虫疫苗中的应用。
10.如权利要求9所述的应用,其特征在于:所述弓形虫基因敲除虫株在体外可以正常培养,虫体可以正常生长复制,但是在体内毒力减弱且诱导动物产生免疫保护力。
CN202210723393.3A 2022-06-24 2022-06-24 缺失6-磷酸葡萄糖酸脱氢酶1基因的弓形虫基因敲除虫株 Active CN114933970B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210723393.3A CN114933970B (zh) 2022-06-24 2022-06-24 缺失6-磷酸葡萄糖酸脱氢酶1基因的弓形虫基因敲除虫株

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210723393.3A CN114933970B (zh) 2022-06-24 2022-06-24 缺失6-磷酸葡萄糖酸脱氢酶1基因的弓形虫基因敲除虫株

Publications (2)

Publication Number Publication Date
CN114933970A true CN114933970A (zh) 2022-08-23
CN114933970B CN114933970B (zh) 2023-03-24

Family

ID=82867801

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210723393.3A Active CN114933970B (zh) 2022-06-24 2022-06-24 缺失6-磷酸葡萄糖酸脱氢酶1基因的弓形虫基因敲除虫株

Country Status (1)

Country Link
CN (1) CN114933970B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116445530A (zh) * 2022-12-14 2023-07-18 华南农业大学 磷酸核糖焦磷酸激酶PrsA基因在制备抗弓形虫病药物中的应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090181056A1 (en) * 2007-10-29 2009-07-16 Bzik David J Toxoplasma gondii mutant with enhanced homologous recombination and uses thereof
US20100203085A1 (en) * 2007-10-29 2010-08-12 Bzik David J Toxoplasma Gondii Vaccines and Uses Thereof
CN107190025A (zh) * 2017-03-15 2017-09-22 华中农业大学 弓形虫乳酸脱氢酶基因敲除虫株的构建方法及用途
CN110093277A (zh) * 2019-03-26 2019-08-06 华中农业大学 弓形虫腺苷酸琥珀酸裂解酶基因敲除虫株的构建方法及用途
CN111154654A (zh) * 2020-02-21 2020-05-15 中国农业大学 一种弓形虫双基因缺失虫株及其构建方法与应用
CN111304088A (zh) * 2020-02-24 2020-06-19 中南大学 一种弓形虫wx2基因缺失株、构建方法及用途
CN114150001A (zh) * 2021-11-05 2022-03-08 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 一种用于弓形虫基因编辑的CRISPR/Cas9载体的构建方法
CN114164114A (zh) * 2021-12-08 2022-03-11 华南农业大学 弓形虫核酮糖-5-磷酸异构酶TgRPI基因编辑虫株及其应用

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090181056A1 (en) * 2007-10-29 2009-07-16 Bzik David J Toxoplasma gondii mutant with enhanced homologous recombination and uses thereof
US20100203085A1 (en) * 2007-10-29 2010-08-12 Bzik David J Toxoplasma Gondii Vaccines and Uses Thereof
CN107190025A (zh) * 2017-03-15 2017-09-22 华中农业大学 弓形虫乳酸脱氢酶基因敲除虫株的构建方法及用途
CN110093277A (zh) * 2019-03-26 2019-08-06 华中农业大学 弓形虫腺苷酸琥珀酸裂解酶基因敲除虫株的构建方法及用途
CN111154654A (zh) * 2020-02-21 2020-05-15 中国农业大学 一种弓形虫双基因缺失虫株及其构建方法与应用
CN111304088A (zh) * 2020-02-24 2020-06-19 中南大学 一种弓形虫wx2基因缺失株、构建方法及用途
CN114150001A (zh) * 2021-11-05 2022-03-08 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 一种用于弓形虫基因编辑的CRISPR/Cas9载体的构建方法
CN114164114A (zh) * 2021-12-08 2022-03-11 华南农业大学 弓形虫核酮糖-5-磷酸异构酶TgRPI基因编辑虫株及其应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BANG SHEN等: "Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii", 《METHODS IN MOLECULAR BIOLOGY》 *
DONG-HUI ZHOU等: "Comparative proteomic analysis of virulent and avirulent strains of Toxoplasma gondii reveals strain-specific patterns", 《ONCOTARGET》 *
MICHAEL D CLEARY等: "Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression", 《EUKARYOT CELL》 *
无: "NCBI Reference Sequence: XM_002366739.2", 《GENE BANK》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116445530A (zh) * 2022-12-14 2023-07-18 华南农业大学 磷酸核糖焦磷酸激酶PrsA基因在制备抗弓形虫病药物中的应用
CN116445530B (zh) * 2022-12-14 2024-03-19 华南农业大学 磷酸核糖焦磷酸激酶prps基因在制备抗弓形虫病药物中的应用

Also Published As

Publication number Publication date
CN114933970B (zh) 2023-03-24

Similar Documents

Publication Publication Date Title
US20020025561A1 (en) Vectors for gene-self-assembly
CN113549618B (zh) 基于RAA扩增和CRISPR-Cas13a系统的SARS-CoV-2核酸检测方法
CN113481327B (zh) 基于RAA扩增和CRISPR-Cas12a的新型冠状病毒ORF1ab基因检测方法
CN108395996B (zh) 一种猪瘟病毒亚单位疫苗及其制备方法和用途
CN108285886A (zh) 重组枯草芽孢杆菌全细胞转化生产n-乙酰神经氨酸的方法
CN108531471B (zh) 一种长基因合成方法
CN114933970B (zh) 缺失6-磷酸葡萄糖酸脱氢酶1基因的弓形虫基因敲除虫株
CN104017827A (zh) 一种慢病毒质粒表达载体及其构建方法和应用
CN104651402A (zh) 通用型基因打靶载体
CN113604505A (zh) pSFV-p32病毒样颗粒及其制备方法和应用
CN107937428B (zh) 一种整合microRNA和CAR功能的载体构建方法
CN114292864B (zh) 高产表面活性素的贝莱斯芽孢杆菌突变株及其构建方法和应用
CN113584223B (zh) 基于CRISPR-Cas12a的SARS-CoV-2中D614G突变鉴定方法
CN109652352B (zh) 一株用于屎肠球菌谷氨酸脱羧酶高效固定化的基因工程菌及固定化方法
CN111321163B (zh) 一种枯草芽孢杆菌线性质粒系统的构建与应用
CN112322706A (zh) 一种特异性人源基因片段及其引物探针和应用
CN107661496A (zh) 一种猪细小病毒免疫组合物及其制备方法与应用
CN112626116B (zh) 定点整合大片段外源dna的方法
CN113073097B (zh) 一种cho细胞内源性的温度敏感型启动子及其应用
CN110607380B (zh) 桑树植原体ltrA基因及其在桑树植原体分子检测中的应用
CN113718047B (zh) 荧光定量方法检测人母乳内10属细菌的试剂盒及其应用
CN114540345B (zh) 一种发夹结构的标签荧光探针和荧光检测方法
CN111378718A (zh) 一种基因测序文库的构建方法
CN114214346B (zh) 靶向肝前体细胞的质粒系统及应用
CN114214347B (zh) 示踪肝前体细胞的质粒系统及应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant